Support MuscleMap
Transforming the future of muscle health
Muscle health is emerging as one of the most important indicators of overall health and disease progression. Yet until now, there has been no reliable way to comprehensively measure or track muscle decline across the body. MuscleMap brings together world-leading clinicians, researchers and AI specialists to create a breakthrough tool capable of detecting subtle changes in muscle composition before serious deterioration occurs. This pioneering approach has the potential to transform diagnosis, rehabilitation and treatment across a wide range of conditions.
When we know what healthy muscles look like, we can identify what diseased muscles look like – and by understanding muscle composition in this level of detail, we can detect disease earlier, personalise treatment, and improve people’s wellbeing.”
– Associate Professor Marnee McKay – Physiotherapist, Researcher & Academic, University of Sydney
A growing global health burden
2 billion people worldwide live with musculoskeletal conditions
1 in 3 Australians
1 in 1,000 Australian children
Muscle loss impacts mobility, independence and quality of life and is increasingly recognised as an early warning sign of chronic illnesses including cancer, diabetes and cardiovascular disease. As populations age and chronic disease rates rise, the need for earlier detection and more personalised treatment has never been greater.
A critical gap in muscle health detection
Despite the growing burden of muscle-related disease, clinicians have lacked the tools to accurately measure and monitor muscle health across the body. This limits the ability to detect disease early, understand progression or evaluate treatment effectiveness. For patients, this can mean delayed diagnosis, reduced mobility, increased disability and poorer long-term outcomes.
“What really matters to me is that we are making a positive impact on people’s lives – their health, their performance, and their wellbeing.”
– Professor James Elliott – Academic Director, Kolling Institute

A world-first solution powered by artificial intelligence
Using advanced artificial intelligence and imaging technologies, MuscleMap has created the world’s first open-source global map of skeletal muscle composition. The platform enables clinicians and researchers to identify changes in muscle health with unprecedented precision, creating new opportunities for earlier intervention and personalised care.
Through this approach, MuscleMap will:
- Detect early signs of muscle wasting and disease progression
- Support more personalised therapies and rehabilitation strategies
- Accelerate clinical trials using muscle health as a measurable outcome
- Build an open-source global resource to support researchers and clinicians worldwide
- Strengthen collaborations with leading international institutions including Stanford University, NASA and the European Space Agency
“MuscleMap encompasses the whole spectrum of research, from bench to bedside.”
– Dr Kenneth Weber, Stanford School of Medicine
From scientific discovery to global patient impact
MuscleMap is already driving breakthroughs across multiple disease areas including Charcot-Marie-Tooth disease, pelvic floor dysfunction and space medicine partnering with NASA.
Your support will help:
- Accelerate earlier disease detection and personalised treatment
- Expand the global muscle health dataset and AI infrastructure
- Support world-first collaborations linking AI, imaging and muscle health
- Build a scalable, open-source clinical resource benefiting patients worldwide
Total investment needed: $2.34M over 3 years
Related Clinical Trial Projects
NORTH STAR Van Norton Poche
Cancer Cellular Immunotherapy Service
Liquid Biopsies
Early Detection of Coronary Artery Disease
UP-STREAM
IRONHEART-CKD
Triggered Acute Risk Prevention (TARP)
Pathways of Care for Traumatic Injuries (PACE-TRI)
Adaptive Platform for Sepsis Care
Healthy Sleep for Healthy Hearts